[California Life Sciences' Spring Innovation Showcase]
- [NEWS] MoneyDJ理財網 : Pharmasaga to List on Emerging Stock Market on 27th; Type 2 Diabetes Phase Ib Clinical Trial Aims for Completion Next Year
- [NEWS] 富聯網 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] 富聯網 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 旺得富 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 旺得富 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 時報資訊 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 財訊快報 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] GENE ONLINE: Pharmasaga Wins Bronze Medal for Innovative Technology at the 2025 Taipei Biotech Awards
- [NEWS] NTTC: NSTC Leads 8 Biomedical Startups into BIO USA 2025; Pharmasaga Advances to Global Competition Finals Again
- [NEWS] 環球生技 : Pharmasaga's Innovative Diabetes Drug PS1 Demonstrates Curative Potential, Initiates Taiwan-US Clinical Trials
- [NEWS] 經濟部 : BIO 2025 North America Biotech Exhibition Opens; Taiwan Pavilion Showcases Taiwan's Innovative Biomedical Technology
- [NEWS] GENE ONLINE : Taiwan Participates in BIO 2025 North America Biotech Exhibition with Dual Focus on All-Age Healthcare Layout and International Connections
- [NEWS] 環球生技 : NSTC Leads 8 Biomedical Startups to BIO 2025; Pharmasaga Reaches Finals Again
- [NEWS] Yahoo新聞 : Taiwan Pavilion Showcases Taiwan's Biomedical Technology at North America Biotech Exhibition
- [NEWS] Yahoo股市 : BIO 2025 North America Biotech Exhibition: Taiwan Pavilion Highlights 5 Biomedical Innovations
- [NEWS] Ltvnews : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
- [NEWS] Biomedical Technology Development
- [NEWS] 工商時報 : (Industry) Taiwanese Companies Attend BIO 2025 North America Biotech Exhibition; Ministry of Economic Affairs Reveals 5 Highlights
- [NEWS] CENS : NSTC Leads 8 Biomedical Startups to BIO Exhibition in the US, Aiming for International Licensing and Investment
- [NEWS] GOTHE : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
[Pharmasaga participate in Bio+Health Track Dinner]
[Pharmasaga participate in SkyDeck x ITRI : Innovation, investment and Global Startup Growth]
[Pharmasaga participate in ITRI : Pitch and Investor Meetup]
[Pharmasaga participate in Berkeley SkyDeck Pitch Day]
A monumental milestone for Pharmasaga (7878.TW) as we advance into the global diabetes treatment market! We are thrilled to announce that we have officially received the prestigious TREE Program subsidy grant from the Department of Industrial Technology, MoEA.
By Reporter 吳典叡 / Comprehensive Report
The US BIO International Convention is a major global event on the global biotechnology and pharmaceutical sector calendar, bringing together top pharmaceutical companies, biotech startups, and investors from around the world. The convention offers extensive opportunities for business collaboration, particularly in licensing, technology transfer,...
Pharmasaga officially initiated its Phase I clinical trial in December 2023, following dual approval from the Taiwan Food and Drug Administration (TFDA) and the U.S. Food and Drug Administration (USFDA).